This invention discloses a pyrrolobenzene derivative compound, its preparation method, and its pharmaceutical application, belonging to the field of chemical pharmaceutical raw materials and formulation
manufacturing technology. The compound has the structure shown. This compound specifically binds to the SGLT-2
protein through a pyrrolobenzene
conjugated system, inhibiting its glucose transport function and affecting the IC50 of SGLT-2. 50 Values range from 15 to 105 nM. Suitable for preparing drugs to treat non-
alcoholic liver disease,
solid tumors, hematological malignancies, and autoimmune diseases, especially effective against
abnormal glucose and
lipid metabolism in hepatocytes and energy deprivation in
tumor cells. The compound possesses enhanced
metabolic stability due to its deuterated group and can be formulated into tablets, capsules, injections, and other dosage forms.